The Complementary Role of Transcription Factors in the Accurate Diagnosis of Clinically Nonfunctioning Pituitary Adenomas
- PMID: 26481628
- DOI: 10.1007/s12022-015-9398-z
The Complementary Role of Transcription Factors in the Accurate Diagnosis of Clinically Nonfunctioning Pituitary Adenomas
Abstract
Clinically nonfunctioning pituitary adenomas (NFAs) may be hormonally inactive tumors of differentiated cells, mainly not only gonadotroph adenomas (GAs) but also silent corticotroph adenomas (SCAs) and other differentiated silent adenomas. Recently, the use of transcription factors has been recommended to confirm cytodiffererentiation of these neoplasms. Our objective was to assess the clinical significance of the new classification system using transcription factors. Five hundred sixteen consecutive NFAs were studied retrospectively. They were initially classified based on hormone immunohistochemistry as follows: 119 hormone-negative adenomas (23.1 %), 300 GAs (58.1 %), 51 SCAs (9.9 %), and 46 other silent adenomas. The 119 hormone-negative adenomas were further evaluated for expression of transcription factors including steroidogenic factor-1 (SF-1), estrogen receptor-α (ERα), pituitary-specific transcription factor 1 (Pit-1), and t-box transcription factor (Tpit). One hundred thirteen of 119 (95 %) hormone-negative adenomas showed mutually exclusive lineage-specific differentiation as gonadotrophs (SF-1 positive), corticotrophs (Tpit positive), or somatotrophs/mammosomatotrophs/lactotrophs/thyrotrophs (Pit-1 positive) in 79 cases (66.4 %), 32 cases (26.9 %), and 2 cases, respectively. The 32 ACTH-negative and Tpit-positive adenomas had higher pro-opiomelanocortin mRNA expression levels compared with GAs (P = 0.0001) on quantitative real-time PCR. They showed a female preponderance (P < 0.0001) and were more frequently giant adenomas (P = 0.0028) associated with marked cavernous sinus invasion (P < 0.0001) compared with GAs. These clinical features were identical to those of the 51 ACTH-positive SCAs. Our results justify the complementary role of transcription factors in the precise classification of NFAs that can more accurately characterize biological behavior. Our data suggest that more than one quarter of hormone-negative adenomas are SCAs that share distinct clinicopathological features with ACTH-expressing SCAs.
Keywords: Nonfunctioning pituitary adenomas; Pit-1; SF-1; Silent adenomas; Tpit; Transcription factors.
Similar articles
-
The Role of T-box Transcription Factor in a Pituitary Adenoma Diagnostic Algorithm.Arch Pathol Lab Med. 2021 May 1;145(5):592-598. doi: 10.5858/arpa.2020-0091-OA. Arch Pathol Lab Med. 2021. PMID: 32991684
-
Clinical Parameters of Silent Corticotroph Adenomas With Positive and Negative Adrenocorticotropic Hormone Immunostaining: A Large Retrospective Single-Center Study of 105 Cases.Front Endocrinol (Lausanne). 2021 Jan 18;11:608691. doi: 10.3389/fendo.2020.608691. eCollection 2020. Front Endocrinol (Lausanne). 2021. PMID: 33584540 Free PMC article.
-
Silent corticogonadotroph adenomas: clinical and cellular characteristics and long-term outcomes.Horm Cancer. 2010 Apr;1(2):80-92. doi: 10.1007/s12672-010-0014-x. Horm Cancer. 2010. PMID: 20717480 Free PMC article.
-
Predictors of silent corticotroph adenoma recurrence; a large retrospective single center study and systematic literature review.Pituitary. 2018 Feb;21(1):32-40. doi: 10.1007/s11102-017-0844-4. Pituitary. 2018. PMID: 29032459 Review.
-
Silent corticotroph adenomas.Pituitary. 2018 Apr;21(2):183-193. doi: 10.1007/s11102-018-0864-8. Pituitary. 2018. PMID: 29344907 Review.
Cited by
-
Development of a cost-effective diagnostic algorithm incorporating transcription factor immunohistochemistry in the evaluation of pituitary tumours.Pituitary. 2022 Dec;25(6):997-1003. doi: 10.1007/s11102-022-01284-2. Epub 2022 Oct 22. Pituitary. 2022. PMID: 36271964 Free PMC article.
-
Microscopic Transsphenoidal Resection of Giant Pituitary Adenomas: Analysis of the Factors Limiting the Degree of Resection in 73 Cases.Front Neurol. 2022 May 27;13:880732. doi: 10.3389/fneur.2022.880732. eCollection 2022. Front Neurol. 2022. PMID: 35711254 Free PMC article.
-
An Update on Silent Corticotroph Adenomas: Diagnosis, Mechanisms, Clinical Features, and Management.Cancers (Basel). 2021 Dec 6;13(23):6134. doi: 10.3390/cancers13236134. Cancers (Basel). 2021. PMID: 34885244 Free PMC article. Review.
-
Immunohistochemical Study of NR2C2, BTG2, TBX19, and CDK2 Expression in 31 Paired Primary/Recurrent Nonfunctioning Pituitary Adenomas.Int J Endocrinol. 2019 May 16;2019:5731639. doi: 10.1155/2019/5731639. eCollection 2019. Int J Endocrinol. 2019. PMID: 31223310 Free PMC article.
-
FSH Levels Are Related to E-cadherin Expression and Subcellular Location in Nonfunctioning Pituitary Tumors.J Clin Endocrinol Metab. 2020 Aug 1;105(8):2587-94. doi: 10.1210/clinem/dgaa281. J Clin Endocrinol Metab. 2020. PMID: 32421791 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical